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Here, we report the case of a patient 
presenting CTEPH recurrence five years after the 
first pulmonary thromboendarterectomy and 
requiring reoperative thromboendarterectomy 
for the resolution of the symptoms.
Case report
A 28-year-old female patient presented 
with progressive dyspnea on exertion and chest 
pain for two months. Se had been submitted to 
pulmonary thromboendarterectomy five years 
prior, thereafter receiving warfarin, which had 
been discontinued one year prior. An electro-
Introduction
Thromboendarterectomy has been established 
as the treatment of choice in the treatment of 
chronic thromboembolic pulmonary hyperten-
sion (CTEPH), providing, in the majority of cases, 
a consistent, definitive alternative for treating 
patients with this disease, with satisfactory short- 
and long-term results.(1,2) Recurrence of CTEPH after 
the first surgical treatment is rare, seen in 1.5% of 
the patients evaluated in the only case series study 
of such patients in the international literature.(3) 
However, reoperative thromboendarterectomy in 
patients presenting recurrence of CTEPH has not 
been reported in the national literature, its safety 
and effectiveness therefore remaining unclear.
Repeat pulmonary thromboendarterectomy after recurrence  
of chronic thromboembolic pulmonary hypertension*
Reoperação de tromboendarterectomia pulmonar em  
recidiva de tromboembolismo pulmonar crônico hipertensivo
Walter José Gomes, Carlos Jogi Imaeda, João Alessio Perfeito,  
Petrúcio Abrantes Sarmento, Rodrigo Caetano Souza, Vicente Forte
Abstract
Pulmonary thromboendarterectomy has been established as the standard method for the treatment of chronic 
thromboembolic pulmonary hypertension, with excellent results. However, repeat pulmonary thromboendarterectomy 
due to recurrence of pulmonary embolism has never been reported in the Brazilian literature. Its safety and 
effectiveness remain obscure. We report the case of a patient presenting recurrence of chronic thromboembolic 
pulmonary hypertension five years after the first pulmonary thromboendarterectomy and requiring a second 
operation for resolution of the symptoms.
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Resumo 
A cirurgia de tromboendarterectomia tem se estabelecido como método padrão de tratamento do tromboembo-
lismo pulmonar crônico hipertensivo, com excelentes resultados. Entretanto, a reoperação na recidiva do embolismo 
pulmonar não tem relato na literatura nacional, permanecendo obscuras a sua segurança e efetividade. Relatamos 
o caso de uma paciente com recorrência de tromboembolismo pulmonar crônico hipertensivo ocorrido cinco anos 
após a primeira cirurgia de tromboendarterectomia pulmonar, e que necessitou de reoperação para resolução dos 
sintomas. 
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under continuous treatment with warfarin. A 
control echocardiogram showed the pulmo-
nary artery systolic pressure to be 40 mmHg, 
which remained stable over the following years, 
together with mild tricuspid insufficiency.
Discussion
It is currently estimated that only 3.8% of 
patients initially presenting acute pulmonary 
embolism develop symptomatic CTEPH within 
the following two years.(4) Recurrence of the 
disease after thromboendarterectomy is even 
more rarely reported.
Among patients with a mean pulmonary 
artery pressure greater than 30 mmHg, the five-
year survival rate is 30%. If the mean pulmonary 
artery pressure exceeds 50 mmHg, the five-year 
survival rate drops to only 10%.(5) Other than 
lung transplantation, pulmonary thromboendar-
terectomy is the only effective treatment for this 
disease, although it carries considerable risk, the 
reported mortality ranging from 6.6% to 23%. (6) 
The most common causes of post-operative 
mortality are reperfusion edema of the lungs, 
massive hemoptysis, right ventricular insuffi-
ciency, respiratory failure and multiple organ 
failure. In addition, pulmonary thromboendarter-
ectomy does not always result in normalization 
of pulmonary vascular resistance, principally due 
to the concomitant peripheral lung injury.
Patients submitted to pulmonary thromboen-
darterectomy require lifelong anticoagulation 
cardiogram showed signs of right ventricular 
overload, and a chest X-ray revealed a moderate 
increase in the cardiac silhouette, with promi-
nence of the pulmonary artery.
An echocardiogram revealed right atrial 
enlargement, with a dilated, hypokinetic right 
ventricle, as well as mild to moderate tricuspid 
insufficiency. We observed two thrombi, one 
occluding the left pulmonary artery and the 
other in the right atrium near the junction with 
the superior vena cava. The pulmonary artery 
systolic pressure was estimated at 65 mmHg.
A CT scan of the chest revealed thrombosis 
and occlusion of the left branch of the pulmo-
nary artery (Figure 1).
The patient was again submitted to median 
sternotomy involving extracorporeal circula-
tion and total circulatory arrest, with systemic 
hypothermia at 18°C. Thromboendarterectomy 
of left branch of the pulmonary artery was 
performed, and exploration of the right branch 
revealed no thrombi (Figure 2). In addition, 
the thrombus was removed from the right 
atrium. A Greenfield inferior vena cava filter 
was also inserted. The duration of extracor-
poreal circulation was 109 min, and that of 
total circulatory arrest was 31 min. The patient 
presented favorable post-operative evolution, 
without complications, and was discharged 
from the hospital on post-operative day 5. At 
59 months after the surgery, the condition of 
the patient was categorized as New York Heart 
Association functional class I, and she was 
Figure 1 - Angiography (a) and CT (b) of the pulmonary artery showing the thrombus completely occluding 
the left branch of the pulmonary artery.
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explored. However, there was no evidence of 
contralateral thrombus.
Another adjunct in the prevention of the 
recurrence of pulmonary thromboembolism is 
the placement of a vena cava filter, which was 
not done in the first operation. However, the use 
of an inferior vena cava filter in CTEPH is contro-
versial. Some authors recommend the use of such 
filters to prevent the recurrence of pulmonary 
thromboembolism over the long term, as well as 
during the more risky peri-operative  period. (1,7) 
Nevertheless, other specialists warn that the 
use of these filters can increase the incidence 
of pulmonary embolism and believe that antico-
agulation therapy alone is sufficient to avoid the 
recurrence of this event.(8-10)
The experience acquired in the present case, 
together with the recommendations of national 
and international guidelines, underscores the 
need for the lifelong use of oral anticoagulants, 
as well as the maintenance of anticoagulation 
therapy levels within what are considered to be 
safe limits.
The post-operative evolution was distin-
guished by the absence de complications and 
the rapid recuperation, which demonstrate that 
surgical treatment of this serious condition 
can be performed safely and with a favorable 
outcome.
In conclusion, reoperative pulmonary 
thromboendarterectomy for the treatment of 
recurrence of chronic pulmonary thromboem-
bolism can be performed with an acceptable 
surgical risk, providing long-term functional and 
symptomatic improvement.
therapy. Inadequate levels or discontinuation 
of anticoagulation therapy puts patients at 
risk for recurrence of the disease, as in the case 
reported here.
In the only case series study of reopera-
tive pulmonary thromboendarterectomy, the 
authors found that, for the second procedure, 
peri-operative morbidity was greater than and 
mortality was similar to that resulting from 
the first procedure. In addition, there was less 
long-term post-operative reduction in pulmo-
nary artery pressure after the second procedure. 
However, the patients presented pronounced 
improvement of symptoms during the long-term 
follow-up treatment.(3) Therefore, reoperative 
thromboendarterectomy is preferred over lung 
transplantation or the inexorable evolution to 
right heart failure and death. Despite being 
empirical and analogous to other cardiac proce-
dures, in which a second operation carries an 
increased mortality risk, no such increase was 
observed in the previously cited case series 
study. (3) A satisfactory post-operative evolution 
of our patient corroborates this observation.
Based on the angiographic, tomographic and 
anatomical findings, it was possible to recom-
mend, plan and devise strategies for the surgery. 
In the approach to the pulmonary artery, despite 
the fact that it was a reoperative procedure, the 
plane of dissection between the thrombus and 
the arterial wall was clearly outlined, and it was 
possible to extract a significant part of throm-
boembolic material. For the sake of safety, the 
right branch of the pulmonary artery was also 
Figure 2 - Intra-operative view of the open pulmonary artery, showing the thrombus completely occluding the 
left branch of the pulmonary artery (a) and the thrombus after removal (b).
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